Atrial fibrillation: Are we facing an epidemic?;Fibrilación auricular: ¿estamos ante una epidemia?

Revista Espanola de Cardiologia

Volumn 62, Issue 1, 2009, Pages 10-14

  Moro Serrano, Concepción ^a   Hernández Madrid, Antonio ^a  

^a UNIVERSITY OF ALCALÁ   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIARRHYTHMIC AGENT; AZIMILIDE; PLACEBO;

ADULT; AGED; CARDIOVERSION; EDITORIAL; ELECTROCARDIOGRAM; EPIDEMIC; FEMALE; HEART ATRIUM ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; OBESITY; PREVALENCE; RACE DIFFERENCE; RISK FACTOR; TREATMENT OUTCOME; AGING; CLASSIFICATION; PHYSIOLOGY; RISK; UNITED STATES;

AGED; AGING; ATRIAL FIBRILLATION; DISEASE OUTBREAKS; HUMANS; RISK; UNITED STATES;

EID: 59949089566     PISSN: 03008932     EISSN: 15792242     Source Type: Journal    
DOI: 10.1016/S0300-8932(09)70015-6     Document Type: Editorial

References (28)

1. Braunwald E. Shattuck lecture - Cardiovascular medicine at the turn of the millennium: triumphs, concerns, and opportunities. N Engl J Med 337 (1997) 1360-1369
2. Lip G.Y. Atrial fibrillation -the growing epidemic. Heart 93 (2007) 542-543
3. Furberg C.D., Psaty B.M., Manolio T.A., Gardin J.M., Smith V.E., and Rautaharju P.M. Prevalence of atrial fibrillation in elderly subjects (the cardiovascular health study). Am J Cardiol 74 (1994) 236-241
4. Wolf P.A., Abbott R.D., Savage D.D., and McNamara P.M. Epidemiologic features of chronic atrial fibrillation. The Framingham study. N Engl J Med 306 (1982) 1018-1022
5. Go A.S., Hylek E.M., Phillips K.A., Chang Y.C., Henault L.E., Selby J.V., et al. Prevalence of diagnosed atrial fibrillation in adults. National implications for rhythm management and stroke prevention. The anticoagulation and risk factors in atrial fibrillation (ATRIA) study. JAMA 285 (2001) 2370-2375
6. Feinberg W.M., Blackshear J.L., Laupacis A., Kronnal R., and Hart R.G. Prevalence, age, distribution and gender of patients with atrial fibrillation: analysis and implications. Arch Intern Med 155 (1995) 469-473
7. Chen L.Y., and Shen W.K. Epidemiology of atrial fibrillation: a current perspective. Heart Rhythm 4 (2007) S1-S6
8. Kannel W.B., and Benjamin E.J. Epidemiology of atrial fibrillation. Med Clin North Am 92 (2008) 17
9. Levy S., Maarek M., Coumel P., Guize L., Lekieffre J., Medvedowsky J.l., et al. Characterization of different subsets of atrial fibrillation in general practice in France: the ALFA study: the College of French Cardiologists. Circulation 99 (1999) 3028-3035
10. Misayaka Y., Barnes M.E., Gersh B.J., Cha S.S., Bailey K.R., Abhayaratna W.P., et al. Secular trends in incidence of atrial fibrillation in Olmsted county Minnesota, 1980 to 2000 and implications on the projection for future prevalence. Circulation 114 (2006) 119-125
11. Heeringa J., Van der Kuip D.A., Hofman A., Kors J.A., Van Herpen G., Stricker B.H., et al. Prevalence, incidence and life time risk of atrial fibrillation: the Rotterdam study. Eur Heart J 27 (2006) 949-953
12. Murphy N.F., Simpson C.R., Jhund P.S., Stewart S., Kirpatrick M., Chalmers J., et al. A national survey of the prevalence, incidence, primary care burden and treatment of atrial fibrillation in Scotland. Heart 93 (2007) 606-612
13. García Acuña J.M., González Juanatey J.R., Alegría E., González I., and Listerri J.L. La fibrilación auricular permanente en las enfermedades cardiovasculares en España. Estudio CARDIOTENS 1999. Rev Esp Cardiol 55 (2002) 943-952
14. Cea Calvo L., Redón J., Lozano J.V., Fernández-Pérez C., Martí J.C., Listerri J., et al., En representación de los investigadores del estudio PREV-ICTUS. Prevalencia de fibrilación auricular en la población española de 60 o más años de edad. Estudio PREV-ICTUS. Rev Esp Cardiol 60 (2007) 616-624
15. Candel F.J., Matesanz M., Cogolludo F., Candel I., Mora C., Bescos T., et al. Prevalencia de fibrilación auricular y factores relacionados en una población del centro de Madrid. Rev Clin Esp 203 (2003) 570-576
16. Vázquez E., Muñoz J., Lozano C., Ramírez A., Guzmán M., Tarabini A., et al. Análisis de las arritmias cardiacas y los trastornos de conducción desde una perspectiva asistencial. Rev Esp Cardiol 58 (2005) 657-665
17. Ruo B., Capra A.M., Jensvold N.G., and Go A.S. Racial variation in the prevalence of atrial fibrillation among patients with heart failure. The epidemiology, practice, outcomes and costs of heart failure (EPOCH) study. J Am Coll Cardiol 43 (2004) 429-435
18. Kirchhof P., Auricchio A., Bax J., Crijns H., Camm J., Dienes H.C., et al. Outcome parameters for trials in atrial fibrillation: executive summary. Eur Heart J 28 (2007) 2803-2817
19. Page R.L., Tilsch T.W., Connolly S.J., Schnell D.J., Marcello S.R., Wilkinson W.E., et al. Asymptomatic or silent atrial fibrillation: frequency in untreated patients and patients receiving azimilide. Circulation 107 (2003) 1141-1145
20. Israel C.W., Grönefeld G., Ehrlich J.R., Li Y.G., and Honhloser S.H. Long term risk of recurrent atrial fibrillation as documented by an implantable monitoring device. J Am Coll Cardiol 43 (2004) 47-52
21. Wang T.J., Parise H., Levy D., D'Agostino R.B., Wolf P.H., Vasan R.S., et al. Obesity and the risk of new onset atrial fibrillation. JAMA 292 (2004) 2471-2476
22. Molina L., Mont L., Marrugat J., Berruezo A., Brugada J., Bruguera J., et al. Long term endurance sport practice increases the incidence of lone atrial fibrillation in men. A follow up study. Europace 10 (2008) 618-623
23. Brugada R., Tapscot T., Czernuszewicz G.Z., Marian A.J., Iglesias A., Mont L., et al. Identification of a genetic locus for familiar atrial fibrillation. N Engl J Med 336 (1997) 905-911
24. Pappone C., Augello G., Sala S., Gugliotta F., Vicedomini G., Gulletta S., et al. A randomized trial of circumferential pulmonary vein ablation versus antiarrhythmic drug therapy in paroxysmal atrial fibrillation. J Am Coll Cardiol 48 (2006) 2340-2347
25. Haïssaguerre M., Jaïs P., Shah D.C., Garrigue S., Takahashi A., Lavergne T., et al. Electrophysiological end point for catheter ablation of atrial fibrillation initiated from multiple pulmonary venous foci. Circulation 101 (2000) 1409-1417
26. Val Gelder I.C., Hagens V.E., Bosker H.A., Kingma J.H., Kamp O., Kingman T., et al. A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation. N Engl J Med 347 (2002) 1834-1840
27. The AFFIRM investigators. Baseline characteristics of patients with atrial fibrillation: the AFFIRM study. Am Heart J 143 (2002) 991-1001
28. Alegre J.M., Viñolas J., Sagrista J.H., Madrid A., Berruezo A., Moya A., et al. Perfil clínico de los pacientes con fibrilación auricular persistente remitidos a cardioversión. Registro sobre cardioversión en España (REVERSE). Rev Esp Cardiol 61 (2008) 630-634